In the BioHarmony Drug Report Database
Anisindione
Miradon (anisindione) is a small molecule pharmaceutical. Anisindione was first approved as Miradon on 1982-01-01. It is used to treat atrial fibrillation, coronary occlusion, embolism, myocardial infarction, and pulmonary embolism amongst others in the USA. The pharmaceutical is active against vitamin K-dependent gamma-carboxylase.
Trade Name
|
Miradon |
|---|---|
Common Name
|
anisindione |
ChEMBL ID
|
CHEMBL712 |
Indication
|
atrial fibrillation, coronary occlusion, embolism, myocardial infarction, pulmonary embolism, thromboembolism, venous thrombosis |
Drug Class
|
Image (chem structure or protein)